Subclinical Left Ventricular Dysfunction During Chemotherapy
Subclinical left ventricular dysfunction is the most common cardiac complication after chemotherapy administration. Detection and early treatment are major issues for better cardiac outcomes in this cancer population. The most common definition of cardiotoxicity is a 10-percentage point decrease of...
Guardado en:
Autores principales: | Martin Nicol, Mathilde Baudet, Alain Cohen-Solal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d54911864c4841cab1ed25766781d4e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors
por: Erez Marcusohn, et al.
Publicado: (2021) -
Improvement in cardiac function after renal transplantation in four patients with severe left ventricular systolic dysfunction
por: Emre Aslanger, et al.
Publicado: (2021) -
Idiopathic Left Ventricular Tachycardia Originating in the Left Posterior Fascicle
por: Hongwu Chen, et al.
Publicado: (2020) -
Physiology and Practicality of Left Ventricular Septal Pacing
por: Luuk Heckman, et al.
Publicado: (2021) -
Asymptomatic Left Ventricle Systolic Dysfunction
por: Jaskanwal D Sara, et al.
Publicado: (2020)